Baxter & Gilead Make Money From Swine Flu

Lee Brodie
CNBC
Tuesday, April 28, 2009

Stocks traded modestly lower by mid-day Monday. New details about the swine flu gave health care and biotech names a boost but dragged down the airlines, hotels and other travel & leisure names.

Shares of Baxter, GlaxoSmithKline, Crucell and Gilead all made gains on the potential that they could benefit from vaccines and treatments.

Both Crucell and Gilead are names that I’m watching explains Jon Najarian, because they both have a great deal of vaccine exposure. But they’re also trading down to their session lows, which suggests the panic may be abating.

Of course, there will be companies that make money from swine flu -- it seems to me GlaxoSmithKline and Baxter are probably good plays on that, Najarian adds.

Full article here